EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Moderna (MRNA) Valuation Check After Upgraded 2025 Outlook And Pipeline Update At J.P. Morgan Conference
Best Biotech Stocks To Keep An Eye On - January 14th - Markets Daily
Moderna (MRNA) Stock: Biotech Leader Surges 30% on Updated Guidance
Moderna (MRNA) Rockets 17% on Strong Preliminary FY25 Results
Trending tickers: Nvidia, Intel, Moderna, BP and Vistry
Adobe stock downgraded, Moderna surges on upbeat guidance
Moderna (NASDAQ:MRNA) Shares Up 7.1% - Still a Buy?
Moderna (NASDAQ:MRNA) Trading 7.1% Higher - Here's Why - Stock Observer
Moderna Chair Says US Assault on Science Is Just Beginning (3)
Biotech Stocks To Add to Your Watchlist - January 11th - Stock Observer
Top Biotech Stocks To Research - January 10th - Stock Observer
Promising Biotech Stocks To Keep An Eye On - January 9th - Stock Observer
Moderna (MRNA) Is Up 14.8% After Advancing Its mRNA Flu Vaccine Toward Regulatory Approvals
Monsanto Sues COVID-19 Vaccine Manufacturers, Alleging Copyright Infringement | ZeroHedge
Fostering innovation through experimentation
Bayer sues Pfizer, Moderna, J&J and BioNTech over alleged Covid vaccine patent breach | Malay Mail
Moderna just had its best day since October. Here's what's going on, and what analysts expect
Bayer sues Covid-jab makers, alleging patent violation
Bayer's Monsanto Files Lawsuit Against Pfizer, BioNTech, and Moderna Over mRNA Patent Infringement, ETPharma
Moderna (MRNA) Valuation Check As mRNA Flu Vaccine Filings Open a New Respiratory Revenue Path
Adjuvanted influenza vaccination increases pre-existing H5N1 cross-reactive antibodies
Chip stocks jump on AI optimism; Dow ends at record high
Biotech Stocks To Watch Today - January 3rd - Stock Observer
Top Biotech Stocks To Watch Now - January 2nd - Daily Political
Mixed options sentiment in Moderna with shares down 0.64% | Markets Insider
Legal Advantage Investments Inc. Takes $1.24 Million Position in Moderna, Inc. $MRNA - Markets Daily
Novavax COVID-19 vaccine available at some GP clinics until May 31
Cwm LLC Purchases 130,200 Shares of Moderna, Inc. $MRNA
Voya Investment Management LLC Decreases Stake in Moderna, Inc. $MRNA
TB Alternative Assets Ltd. Sells 602,072 Shares of Moderna, Inc. $MRNA
Forget Moderna Stock, This is a Much Better Buy
Could CEPI's Bird Flu Backing Mark a Turning Point in Moderna (MRNA)'s mRNA Diversification Strategy?
Moderna (NASDAQ:MRNA) Stock Price Down 5.8% - Here's What Happened - Daily Political
Mixed options sentiment in Moderna with shares down 6.28% | Markets Insider
Moderna (NASDAQ:MRNA) Trading Down 5.8% - Here's Why
Moderna, Inc. (NASDAQ:MRNA) Receives Consensus Rating of "Reduce" from Brokerages
Moderna, Inc. $MRNA Shares Bought by Douglas Lane & Associates LLC
MRNA: Oncology Advances And Buyout Optionality Will Offset Debt And Litigation Risks
Moderna (MRNA): Valuation Check After CEPI Backs Phase 3 Trial for Its mRNA Bird Flu Vaccine
Top Biotech Stocks To Add to Your Watchlist - December 20th - Markets Daily
Promising Biotech Stocks To Follow Now - December 19th - Daily Political
There's No Escaping Moderna, Inc.'s (NASDAQ:MRNA) Muted Revenues Despite A 28% Share Price Rise - Simply Wall St News
Moderna Inc Stock Live Price, Chart, Analysis, News & Forecast - Buy, Sell & Trade US Equities Today
Moderna (MRNA) Valuation Check as CEPI Backs Phase 3 H5 Bird Flu Vaccine with $54.3 Million Funding
Moderna, Inc. (MRNA): A Bull Case Theory
Why Moderna (MRNA) Stock Is Up Today
Moderna Gets Bird Flu Shot Funding After HHS Ends Contract (1)
Moderna secures up to $54.3 million funding for bird flu vaccine from global coalition - Yahoo News Canada
Moderna to get $54.3M for bird flu vaccine research
Metavalis Inc. Initiates Centralizing Critical Biotech Infrastructure In The American Interior -- Metavalis Inc. | PRLog
Moderna (NASDAQ:MRNA) Trading 5.3% Higher - Should You Buy?
Moderna (NASDAQ:MRNA) Trading 5.3% Higher - Here's What Happened - Markets Daily
John Dorfman: 5 flattened stocks - Biggest losers of 2025 | TribLIVE.com
Moderna (MRNA) Is Up 5.9% After EMA Backs New mNEXSPIKE Vaccine - Has The Bull Case Changed?
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
